The healthcare landscape in 2026 is witnessing a massive transition toward individualized care, where "one-size-fits-all" medicine is being replaced by data-driven biological insights. The industry is currently centered on the discovery and validation of specific molecules that indicate health or disease states, allowing for earlier intervention in chronic conditions like cancer and...
Market Overview
The global cardiac biomarkers market size was valued at USD 19.21 billion in 2024 and is projected to grow from USD 21.94 billion in 2025 to reach USD 63.46 billion in 2033, growing at a CAGR of 14.2% during the forecast period (2025–2033).
The global Cardiac Biomarkers market continues to...
In early 2026, the concept of "Biological Age" has moved from the lab to the mainstream "Longevity Clinic." The primary tool for this is the "Epigenetic Clock," which measures "DNA Methylation" patterns—the chemical "tags" that turn genes on or off as we age. Unlike your chronological age, your "Bio-Age" is a biomarker of how well your cells are actually functioning. In early 2026, these...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
thai
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china